ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call
In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 24, 2018.
A Pharma Trade From Goldman
Jayson Derrick outlines a bull and bear call on Catelent, Inc (NYSE: CTLT) and Valeant Pharmaceuticals International, Inc (NYSE: VRX), respectively, from Goldman Sachs. Check out “Goldman Sachs On Specialty Pharma: Buy Catalent, Sell Valeant.”
Puma Biotech Declawed By European Medicines Agency
Puma Biotechnology, Inc (NASDAQ: PBYI) shares were crushed Wednesday after reporting a negative trend vote from European regulators regarding its neratinib compound. Learn more in Shanthi Rexaline’s “What You Need to Know About Puma Biotech's 25% Slide.”
Related Link: With EU Approval For Puma Biotech's Breast Cancer Drug Unlikely, Cowen Downgrades
'3 Micro-Cap Tech Stocks To Watch In 2018'
Bill Haddad checked out the LD Micro Virtual CES Wrap Up so that you don’t have to. From Vuzix Corporation (NASDAQ: VUZI) to My Size, Inc (NASDAQ: MYSZ), learn why these names are worth keeping an eye on this year.
Latest Ratings for VRX
Date | Firm | Action | From | To |
---|---|---|---|---|
Jun 2018 | TD Securities | Downgrades | Buy | Hold |
Jun 2018 | Barclays | Upgrades | Equal-Weight | Overweight |
May 2018 | Mizuho | Upgrades | Neutral | Buy |
View More Analyst Ratings for VRX
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Analyst Color Biotech News Previews Small Cap After-Hours Center Analyst Ratings Trading Ideas Best of Benzinga